Chemotherapy Articles | Chemotherapy Links | Chemotherapy Partners | Chemotherapy Sitemap






















Index of All Articles in the Dose Dense Chemotherapy Category


Defined Tag:


The Advantage of Dose Dense chemotherapy

The development of dose dense chemotherapy is presenting amazing results in breast cancer treatment With this new form of therapy, the period between chemotherapy doses have been shortened and results for women whose cancer has expanded to the lymph nodes
Read More...













Chemotherapy News and Events
Google


Cancer survivor follows mom into Hall of Fame (San Diego Union-Tribune)

Thu, 28 Aug 2008 13:08:21 GMT

Connie Palmer didn't think she would live to see 46. With her health as it was, no one could blame her. Palmer's breast cancer was at an advanced stage, and her five-month session of chemotherapy was taking its toll.


FDA Approves ALOXI(R) (Palonosetron HCl) Capsules For Prevention Of Acute Chemotherapy Induced Nausea And Vomiting (Medical News Today)

Sun, 24 Aug 2008 11:14:01 GMT

Eisai Corporation of North America and its partner Helsinn Healthcare SA announced that the U.S. Food and Drug Administration (FDA) has approved a new oral formulation of ALOXI(R) (palonosetron hydrochloride) for the prevention of chemotherapy-induced nausea and vomiting (CINV). ALOXI Capsules 0.


Synta Announces Publication Of Elesclomol Mechanism Of Action Results In AACR Journal Molecular Cancer Therapeutics (Medical News Today)

Tue, 26 Aug 2008 11:15:52 GMT

Synta Pharmaceuticals Corp., (NASDAQ: SNTA) announced the publication of new findings in the American Association for Cancer Research journal, Molecular Cancer Therapeutics that describe the novel mechanism of action of elesclomol: driving programmed cell death (apoptosis) in cancer cells through the selective induction of oxidative stress.



© 2008, Chemotherapy - All Rights Reserved Worldwide | Chemotherapy Legal Information